Skip to content

The effect of ginseng on cancer related fatigue and Quality of life in cancer survivors

The effect of ginseng on cancer related fatigue and Quality of life in cancer survivors: a randomized controlled clinical trial study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017101536777N1
Enrollment
80
Registered
2017-10-25
Start date
2017-11-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer. c80.9

Interventions

Intervention 1: In this study, standardized ginseng extract was given to patients in 250 mg capsules daily for four weeks. In order to hide the drug with placebo in similar envelopes, they will be put
Treatment - Drugs
Placebo
In this study, standardized ginseng extract was given to patients in 250 mg capsules daily for four weeks. In order to hide the drug with placebo in similar envelopes, they will be put in matte pack.
In this study, Placebo capsules same as the original medicine, patients are given daily for four weeks. In order to hide the drug with placebo in similar envelopes, they will be put in matte pack. The

Sponsors

Tabriz University of Medical Sciences, Tabriz Faculty of Nursing and Midwifery
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: A definitive diagnosis of cancer according to the opinion of the oncologist Fatigue score above 4 (out of 10) Aged 65-18 years Patients in stage II, I disease. Patients with colorectal , stomach cancer Not having hypertension Not having diabetes Exclusion criteria: Get the anesthetic and narcotic drugs during the study The patient's unwillingness to continue participating in the study Occurrence of acute problems during the study The existence of mental and brain illness in the patient's medical history indicated. Receiving sleep disturbances such as diuretics, antidepressants, inotropes and amphetamines at night Need for cardiopulmonary resuscitation during intervention Pregnant and lactating women Receive oral antidiabetic medicines Coagulation therapy (aspirin, heparin) Having a history of seizure

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Fatigue. Timepoint: before intervention, once month after intervention. Method of measurement: Brief Fatigue Inventory (BFI).

Secondary

MeasureTime frame
Quality of life. Timepoint: before intervention, once month after intervention. Method of measurement: EORTC QLQ-C30 (version 3).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMusab ghaderi

Tabriz University of Medical Sciences, Tabriz Faculty of Nursing and Midwifery

musab.ghaderi@gmail.com+98 937 809 5753

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026